Allergan is recalling two glaucoma medications because laboratory testing found that the products did not meet the regulatory specifications for individual and total impurities. The recall involves seven lots of Combigan (brimoidine tartrate and timolol maleate) and one lot of Lumigan (bimatoprost). Both drugs are ophthalmic solutions used to treat glaucoma and ocular hypertension. Specifically, the recall includes the Combigan 0.2%/0.5%, 5 mL solution with: NDC# 0023-9211-05; Lot# 94715; Expiration date: 1/19 NDC# 0023-9211-05; Lot# 94757; Expiration date: 2/19 NDC# 0023-9211-05; Lot# 94715A; Expiration date: 1/19 NDC# 0023-9211-05; Lot# 95297; Expiration date: 3/19 The 2.5 mL solution with: NDC# 0023-9211-03; ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.